疑难病杂志2024,Vol.23Issue(12) :1515-1518.DOI:10.3969/j.issn.1671-6450.2024.12.020

慢性肾脏病维持性血液透析患者相关贫血发病机制与治疗研究进展

Research progress on pathogenesis and treatment of dialysis-related anemia in maintenance hemodialysis patients with chronic kidney disease

万正红 周莉
疑难病杂志2024,Vol.23Issue(12) :1515-1518.DOI:10.3969/j.issn.1671-6450.2024.12.020

慢性肾脏病维持性血液透析患者相关贫血发病机制与治疗研究进展

Research progress on pathogenesis and treatment of dialysis-related anemia in maintenance hemodialysis patients with chronic kidney disease

万正红 1周莉1
扫码查看

作者信息

  • 1. 610041 成都,四川大学华西医院肾脏内科/血透室
  • 折叠

摘要

贫血是慢性肾脏病(CKD)尤其是维持性血液透析CKD患者常见并发症,既往主要认为与患者红细胞生成不足及损失过多有关,常使用红细胞生成刺激剂进行治疗.近年来随着研究不断深入,骨矿物质代谢异常、甲状腺功能异常等新的发病机制逐渐被发现,且随着罗沙司他、恩那度司他等新药物的研发和应用,CKD维持性血液透析相关贫血的诊疗形势所有改善.文章就CKD维持性血液透析相关贫血特点及治疗方法展开综述,以期为该病的治疗提供新的思路.

Abstract

Anemia is a common complication of chronic kidney disease(CKD),especially in CKD patients with ma-intenance hemodialysis.In the past,anemia was mainly thought to be related to insufficient erythropoiesis and excessive loss in patients,therefore erythropoiesis stimulators were often used for treatment.In recent years,with the deepening of re-search,new pathogenesis such as abnormal bone mineral metabolism and abnormal thyroid function have been gradually discovered,and with the development and application of new drugs such as roxadustat and enarodustat,the diagnosis and treatment situation of CKD maintenance hemodialysis-related anemia has been improved.The study reviews the characteris-tics and treatment methods of CKD maintenance hemodialysis-related anemia in order to provide new ideas for the treatment of the disease.

关键词

慢性肾脏病/维持性血液透析/贫血/治疗

Key words

Chronic kidney disease/Maintenance hemodialysis/Anemia/Treatment

引用本文复制引用

出版年

2024
疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
浏览量1
段落导航相关论文